Aurélie Cointe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Aurélie Cointe has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Stéphane Bonacorsi
Service de Microbiologie, Centre National de Référence Escherichia coli, AP-HP, Hôpital Robert-Debré, Université Paris-Cité, IAME, UMR 1137, INSERM, 75018 Paris, France
4 shared publications - François-Xavier Weill
Institut Pasteur, Université Paris Cité, Unité des Bactéries Pathogènes Entériques, Centre National de Référence des Escherichia coli, Shigella et Salmonella, Paris, France
3 shared publications - Patricia Mariani-Kurkdjian
Microbiology Unit, Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, 75019 Paris, France
3 shared publications - Adrien Joseph
Intensive Care Unit, University Hospital Ambroise Pare, GHU Paris-Saclay, AP-HP, Boulogne-Billancourt, France
2 shared publications - Cédric Rafat
Soins Intensifs Néphrologiques et Rein Aigu, Tenon Hospital, AP-HP, Paris, France
2 shared publications - Delphine Sergentet
Bacterial Opportunistic Pathogens and Environment Research Group, UMR 5557 Ecologie Microbienne Lyon, CNRS, Université de Lyon, VetAgro Sup, INRAE, Marcy-l’Etoile, France
2 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (5) , e0244925
Analysis of the genetic and phylogenetic context of Escherichia coli O77g:H18 associated with clustered cases of HUS in France in 2025
In January 2025, Santé publique France detected several cases of hemolytic uremic syndrome (HUS) in adults caused by a rare serotype of Shiga toxin-producing Escherichia coli , STEC O77g:H18. Epidemiological and traceability investigations linked the consumption of raw-milk cheese to these cases. The outbreak strain belonged to sequence type 69 (ST69) and harbored a Shiga toxin (stx) subtype stx2d located on a unique prophage. Putative virulence genes cdt-VABC , hlyE , fimH , and lpfA were detected; however, STEC virulence genes ( eae and aggR ) were absent. Phylogenetic analysis of E. coli O77g strains from public databases (Enterobase and NCBI) placed the outbreak strain within a cluster of clinical E. coli O77g:H18, ST69, stx2d strains isolated between 2012 and 2025, including one linked to a HUS case in France and three in Australia. This strain, distinct from O77g:H18 strains previously isolated from dairy products, is therefore not a new lineage. The closest cluster contains eight stx -negative strains isolated from poultry between 1990 and 2024 in Europe and North America. Differences in virulence gene composition between the “outbreak cluster” and the “poultry cluster” suggest a common ancestor that has diverged over time. The “outbreak cluster” is characterized by strains carrying an IncFIA/FIB plasmid encoding a putative enterotoxin gene ( elt ) absent in other E. coli strains in GenBank. We developed qPCR assays specific for the putative enterotoxin and O77g O-group. Combined with a PCR for stx2 , these assays allow rapid screening of suspect unpasteurized cheese for the outbreak strain. IMPORTANCE: The emergence of hybrid pathotypes of Shiga toxin-producing Escherichia coli (STEC) has been of importance in recent years in public health. This outbreak, related to a rare serotype of STEC and involving an enterotoxigenic E. coli (ETEC)/STEC hybrid, highlights the necessity of phylogenetic analyses to investigate the origin of contamination with such strains. Our study suggests a common ancestor between the outbreak strain and strains isolated from poultry. We also provided molecular tools to target specifically this outbreak strain and help in future epidemiological investigations.
- 20 May 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (5) , e0244925
Open AccessAnalysis of the genetic and phylogenetic context of Escherichia coli O77g:H18 associated with clustered cases of HUS in France in 2025
In January 2025, Santé publique France detected several cases of hemolytic uremic syndrome (HUS) in adults caused by a rare serotype of Shiga toxin-producing Escherichia coli , STEC O77g:H18. Epidemiological and traceability investigations linked the consumption of raw-milk cheese to these cases. The outbreak strain belonged to sequence type 69 (ST69) and harbored a Shiga toxin (stx) subtype stx2d located on a unique prophage. Putative virulence genes cdt-VABC , hlyE , fimH , and lpfA were detected; however, STEC virulence genes ( eae and aggR ) were absent. Phylogenetic analysis of E. coli O77g strains from public databases (Enterobase and NCBI) placed the outbreak strain within a cluster of clinical E. coli O77g:H18, ST69, stx2d strains isolated between 2012 and 2025, including one linked to a HUS case in France and three in Australia. This strain, distinct from O77g:H18 strains previously isolated from dairy products, is therefore not a new lineage. The closest cluster contains eight stx -negative strains isolated from poultry between 1990 and 2024 in Europe and North America. Differences in virulence gene composition between the “outbreak cluster” and the “poultry cluster” suggest a common ancestor that has diverged over time. The “outbreak cluster” is characterized by strains carrying an IncFIA/FIB plasmid encoding a putative enterotoxin gene ( elt ) absent in other E. coli strains in GenBank. We developed qPCR assays specific for the putative enterotoxin and O77g O-group. Combined with a PCR for stx2 , these assays allow rapid screening of suspect unpasteurized cheese for the outbreak strain. IMPORTANCE: The emergence of hybrid pathotypes of Shiga toxin-producing Escherichia coli (STEC) has been of importance in recent years in public health. This outbreak, related to a rare serotype of STEC and involving an enterotoxigenic E. coli (ETEC)/STEC hybrid, highlights the necessity of phylogenetic analyses to investigate the origin of contamination with such strains. Our study suggests a common ancestor between the outbreak strain and strains isolated from poultry. We also provided molecular tools to target specifically this outbreak strain and help in future epidemiological investigations.
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Emergence d'infections à Escherichia coli de pathotype hybride, producteurs d'une Shiga toxine et associés à une virulence extra-intestinale : caractérisation moléculaire et optimisation de leur prévention et de leur prise en charge
L'épidémiologie des Escherichia coli entérohémorragiques (EHEC) responsables de Syndrome Hémolytique et Urémique (SHU), s'est considérablement modifiée ces dernières années. Un clone atypique de sérotype O80:H2 (Sequence-type ST301) responsable de SHU et d'infections invasives a récemment émergé en Europe. Ce clone possède à la fois des facteurs de virulence (FVs) typiques des EHEC (intimine - eae-xi, Shiga toxine - stx, entérohémolysine - ehxA), des FVs caractéristiques des E. coli pathogènes extra-intestinaux (ExPEC) et une multirésistance aux antibiotiques (ATB). L'objectif de ce travail est de caractériser sur le plan moléculaire et phénotypique cet hétéropathotype afin de comprendre son émergence et de contribuer à l'amélioration du diagnostic, du traitement et de la prévention des infections liées à ce pathogène. Le clone EHEC O80:H2 a acquis un plasmide mosaïque (pR444_A) hautement similaire au plasmide pS88, un déterminant majeur de la virulence des ExPEC, porteur de multiples FVs extra-intestinaux et au sein duquel une cassette de résistance aux ATB s'est insérée. Ce profil d'hétéropathotype ExPEC/EHEC n'est pas restreint à ce seul sérotype puisque au moins 3 autres sérotypes (O55:H9, O45:H2 et O186:H2) porteurs d'un plasmide similaire ont été identifiés au sein du ST301. Une particularité métabolique associée à une cicatrice génétique hautement spécifique du ST301, a été exploitée pour développer une PCR en temps réel (Se=100%, Sp=98,4%) et un milieu de culture (Se=85%, Sp=85%) sélectifs de ces clones. En cas d'infections invasives imposant une antibiothérapie, la production comparée de Stx en présence de différents ATB conduit à recommander l'association d'une béta-lactamine à un inhibiteur de la synthèse protéique. Au travers d'une caractérisation étendue incluant des analyses phénotypiques, génotypiques, phylogénétiques, moléculaires et métaboliques, ce travail participe à l'amélioration de la connaissance des hétéropathotypes ExPEC/EHEC de ST301 et de la prise en charge des infections liées à ces clones. L'importante capacité de ces clones à acquérir du matériel génétique étranger souligne leur extrême plasticité génomique dont les facteurs génétiques sous-jacents restent à découvrir. L'application de ces deux nouvelles méthodes diagnostiques dans l'industrie agro-alimentaire pourrait participer à l'identification du réservoir du clone O80:H2 inconnu jusqu'alors et ainsi contribuer à la prévention de ces infections.
- 6 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Emergence d'infections à Escherichia coli de pathotype hybride, producteurs d'une Shiga toxine et associés à une virulence extra-intestinale : caractérisation moléculaire et optimisation de leur prévention et de leur prise en charge
L'épidémiologie des Escherichia coli entérohémorragiques (EHEC) responsables de Syndrome Hémolytique et Urémique (SHU), s'est considérablement modifiée ces dernières années. Un clone atypique de sérotype O80:H2 (Sequence-type ST301) responsable de SHU et d'infections invasives a récemment émergé en Europe. Ce clone possède à la fois des facteurs de virulence (FVs) typiques des EHEC (intimine - eae-xi, Shiga toxine - stx, entérohémolysine - ehxA), des FVs caractéristiques des E. coli pathogènes extra-intestinaux (ExPEC) et une multirésistance aux antibiotiques (ATB). L'objectif de ce travail est de caractériser sur le plan moléculaire et phénotypique cet hétéropathotype afin de comprendre son émergence et de contribuer à l'amélioration du diagnostic, du traitement et de la prévention des infections liées à ce pathogène. Le clone EHEC O80:H2 a acquis un plasmide mosaïque (pR444_A) hautement similaire au plasmide pS88, un déterminant majeur de la virulence des ExPEC, porteur de multiples FVs extra-intestinaux et au sein duquel une cassette de résistance aux ATB s'est insérée. Ce profil d'hétéropathotype ExPEC/EHEC n'est pas restreint à ce seul sérotype puisque au moins 3 autres sérotypes (O55:H9, O45:H2 et O186:H2) porteurs d'un plasmide similaire ont été identifiés au sein du ST301. Une particularité métabolique associée à une cicatrice génétique hautement spécifique du ST301, a été exploitée pour développer une PCR en temps réel (Se=100%, Sp=98,4%) et un milieu de culture (Se=85%, Sp=85%) sélectifs de ces clones. En cas d'infections invasives imposant une antibiothérapie, la production comparée de Stx en présence de différents ATB conduit à recommander l'association d'une béta-lactamine à un inhibiteur de la synthèse protéique. Au travers d'une caractérisation étendue incluant des analyses phénotypiques, génotypiques, phylogénétiques, moléculaires et métaboliques, ce travail participe à l'amélioration de la connaissance des hétéropathotypes ExPEC/EHEC de ST301 et de la prise en charge des infections liées à ces clones. L'importante capacité de ces clones à acquérir du matériel génétique étranger souligne leur extrême plasticité génomique dont les facteurs génétiques sous-jacents restent à découvrir. L'application de ces deux nouvelles méthodes diagnostiques dans l'industrie agro-alimentaire pourrait participer à l'identification du réservoir du clone O80:H2 inconnu jusqu'alors et ainsi contribuer à la prévention de ces infections.
- Open Access
- 26 February 2026
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 31 (8) , 2500506
Nationwide outbreak of Shiga toxin-producing Escherichia coli infections associated with frozen pizzas, France, 2022
In February 2022, we observed an increase in the number of paediatric patients with haemolytic uraemic syndrome (HUS) associated with Shiga toxin-producing Escherichia coli (STEC) in France. We interviewed cases or caretakers about food exposures, identified purchases on supermarket loyalty cards, conducted a case–control study, tested food samples and characterised isolates. We identified 59 cases of STEC O26:H11 or O103:H2 infections nationwide from 18 January to 5 April 2022. Fifty cases presented with HUS and two died. Data from supermarket loyalty cards identified frequent purchase of Brand A Type B frozen pizzas. A case–control study confirmed a strong association between the consumption of Brand A pizzas and illness (OR = 116.0; 95% confidence interval (CI): 26.8–501.9). Manufacturing of Brand A Type B pizzas did not include pre-baking of the dough. Isolates from pizza dough and flour samples were indistinguishable from the clinical outbreak strains. On 18 March, the manufacturer recalled the Type B pizzas. While flour is a known STEC vehicle, this outbreak is highly unusual, as cooking of frozen pizzas should eliminate STEC. Further research aiming to understand the origins and persistence of contamination should contribute to improving food safety practices.
- 26 February 2026
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 31 (8) , 2500506
Open AccessNationwide outbreak of Shiga toxin-producing Escherichia coli infections associated with frozen pizzas, France, 2022
In February 2022, we observed an increase in the number of paediatric patients with haemolytic uraemic syndrome (HUS) associated with Shiga toxin-producing Escherichia coli (STEC) in France. We interviewed cases or caretakers about food exposures, identified purchases on supermarket loyalty cards, conducted a case–control study, tested food samples and characterised isolates. We identified 59 cases of STEC O26:H11 or O103:H2 infections nationwide from 18 January to 5 April 2022. Fifty cases presented with HUS and two died. Data from supermarket loyalty cards identified frequent purchase of Brand A Type B frozen pizzas. A case–control study confirmed a strong association between the consumption of Brand A pizzas and illness (OR = 116.0; 95% confidence interval (CI): 26.8–501.9). Manufacturing of Brand A Type B pizzas did not include pre-baking of the dough. Isolates from pizza dough and flour samples were indistinguishable from the clinical outbreak strains. On 18 March, the manufacturer recalled the Type B pizzas. While flour is a known STEC vehicle, this outbreak is highly unusual, as cooking of frozen pizzas should eliminate STEC. Further research aiming to understand the origins and persistence of contamination should contribute to improving food safety practices.
- Open Access
- 19 February 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (2) , 001647
Pathogenic potential and phylogenomic analysis of stx2-carrying O26:H11 Shiga toxin-producing Escherichia coli isolated from dairy products in France (2014–2024)
Shiga toxin-producing Escherichia coli (STEC) are major foodborne pathogens causing sporadic enteric disease and paediatric haemolytic uraemic syndrome (HUS) cases globally. In France, STEC O26:H11 strains carrying the stx2 gene have become the leading cause of paediatric HUS over the last decade. Concurrently, data from the French National Reference Laboratory show an increased proportion of stx2 -carrying O26:H11 strains isolated from food, including raw milk products (RMPs). The consumption of RMP contaminated by this specific genotype has been linked to three out of four nationwide outbreaks between 2015 and 2024, confirming its emergence in France with RMPs as a potential source of infections. This study aimed to investigate the population structure, pathogenic potential and evolutionary dynamics of stx2 -carrying O26:H11 STEC strains found in RMP in France. Using Illumina whole-genome sequencing, we (i) conducted a comparative analysis of human clinical strains and RMP isolates based on a set of accessory genes to assess pathogenic potential, (ii) performed phylogenomic analysis and (iii) explored evolutionary dynamics of major stx2 -carrying STEC clonal lineages identified in RMPs using Bayesian evolutionary analysis sampling trees. Our results identified a predominant stx2 -carrying O26:H11 clonal lineage, ST21-cl5, which became predominant in the raw milk production sector across multiple French regions and showed moderate diversification with evolutionary rates consistent with previously reported rates for STEC (i.e. 4.496×10 −7 substitution/site/year). ST21-cl5 isolates from RMP displayed a high pathogenic potential, clustering closely with HUS-associated human isolates in both accessory genetic feature-based and core genome-based analyses. These findings suggest that clinical and RMP ST21-cl5 isolates evolved under similar selective pressures and shared a common ecological niche. Conversely, stx2d -carrying O26:H11 isolates also responsible for human infections in France might stem from a different source, as no stx2d -carrying strain was found among RMP isolates.
- 19 February 2026
- Published by Microbiology Society in Microbial Genomics
- Vol. 12 (2) , 001647
Open AccessPathogenic potential and phylogenomic analysis of stx2-carrying O26:H11 Shiga toxin-producing Escherichia coli isolated from dairy products in France (2014–2024)
Shiga toxin-producing Escherichia coli (STEC) are major foodborne pathogens causing sporadic enteric disease and paediatric haemolytic uraemic syndrome (HUS) cases globally. In France, STEC O26:H11 strains carrying the stx2 gene have become the leading cause of paediatric HUS over the last decade. Concurrently, data from the French National Reference Laboratory show an increased proportion of stx2 -carrying O26:H11 strains isolated from food, including raw milk products (RMPs). The consumption of RMP contaminated by this specific genotype has been linked to three out of four nationwide outbreaks between 2015 and 2024, confirming its emergence in France with RMPs as a potential source of infections. This study aimed to investigate the population structure, pathogenic potential and evolutionary dynamics of stx2 -carrying O26:H11 STEC strains found in RMP in France. Using Illumina whole-genome sequencing, we (i) conducted a comparative analysis of human clinical strains and RMP isolates based on a set of accessory genes to assess pathogenic potential, (ii) performed phylogenomic analysis and (iii) explored evolutionary dynamics of major stx2 -carrying STEC clonal lineages identified in RMPs using Bayesian evolutionary analysis sampling trees. Our results identified a predominant stx2 -carrying O26:H11 clonal lineage, ST21-cl5, which became predominant in the raw milk production sector across multiple French regions and showed moderate diversification with evolutionary rates consistent with previously reported rates for STEC (i.e. 4.496×10 −7 substitution/site/year). ST21-cl5 isolates from RMP displayed a high pathogenic potential, clustering closely with HUS-associated human isolates in both accessory genetic feature-based and core genome-based analyses. These findings suggest that clinical and RMP ST21-cl5 isolates evolved under similar selective pressures and shared a common ecological niche. Conversely, stx2d -carrying O26:H11 isolates also responsible for human infections in France might stem from a different source, as no stx2d -carrying strain was found among RMP isolates.
- Open Access
- 16 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5428
First Isolation of the Heteropathotype Shiga Toxin-Producing and Extra-Intestinal Pathogenic (STEC-ExPEC) E. coli O80:H2 in French Healthy Cattle: Genomic Characterization and Phylogenetic Position
The emerging heteropathotype shigatoxigenic (STEC) and extra-intestinal pathogenic Escherichia coli (ExPEC) O80:H2 has been the second leading cause of pediatric HUS in France since the mid-2010s. In contrast with other highly pathogenic STEC serotypes, for which ruminants have clearly been identified as the main human infection source, this heteropathotype’s reservoir remains unknown. In this context, we describe for the first time the isolation of seven STEC O80:H2 strains from healthy cattle on a single cattle farm in France. This study aimed at (i) characterizing the genome and (ii) investigating the phylogenetic positions of these O80:H2 STEC strains. The virulomes, resistomes, and phylogenetic positions of the seven bovine isolates were investigated using in silico typing tools, antimicrobial susceptibility testing and cgMLST analysis after short-read whole genome sequencing (WGS). One representative isolate (A13P112V1) was also subjected to long-read sequencing. The seven isolates possessed ExPEC-related virulence genes on a pR444_A-like mosaic plasmid, previously described in strain RDEx444 and known to confer multi-drug resistance. All isolates were clonally related and clustered with human clinical strains from France and Switzerland with a range of locus differences of only one to five. In conclusion, our findings suggest that healthy cattle in France could potentially act as a reservoir of the STEC-ExPEC O80:H2 pathotype.
- 16 May 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (10) , 5428
Open AccessFirst Isolation of the Heteropathotype Shiga Toxin-Producing and Extra-Intestinal Pathogenic (STEC-ExPEC) E. coli O80:H2 in French Healthy Cattle: Genomic Characterization and Phylogenetic Position
The emerging heteropathotype shigatoxigenic (STEC) and extra-intestinal pathogenic Escherichia coli (ExPEC) O80:H2 has been the second leading cause of pediatric HUS in France since the mid-2010s. In contrast with other highly pathogenic STEC serotypes, for which ruminants have clearly been identified as the main human infection source, this heteropathotype’s reservoir remains unknown. In this context, we describe for the first time the isolation of seven STEC O80:H2 strains from healthy cattle on a single cattle farm in France. This study aimed at (i) characterizing the genome and (ii) investigating the phylogenetic positions of these O80:H2 STEC strains. The virulomes, resistomes, and phylogenetic positions of the seven bovine isolates were investigated using in silico typing tools, antimicrobial susceptibility testing and cgMLST analysis after short-read whole genome sequencing (WGS). One representative isolate (A13P112V1) was also subjected to long-read sequencing. The seven isolates possessed ExPEC-related virulence genes on a pR444_A-like mosaic plasmid, previously described in strain RDEx444 and known to confer multi-drug resistance. All isolates were clonally related and clustered with human clinical strains from France and Switzerland with a range of locus differences of only one to five. In conclusion, our findings suggest that healthy cattle in France could potentially act as a reservoir of the STEC-ExPEC O80:H2 pathotype.
- Open Access
Emergence of New ST301 Shiga Toxin-Producing Escherichia coli Clones Harboring Extra-Intestinal Virulence Traits in Europe
O80:H2 enterohemorrhagic Escherichia coli (EHEC) of sequence type ST301 is one of the main serotypes causing European hemolytic and uremic syndrome, but also invasive infections, due to extra-intestinal virulence factors (VFs). Here, we determined whether other such heteropathotypes exist among ST301. EnteroBase was screened for ST301 strains that were included in a general SNP-phylogeny. French strains belonging to a new heteropathotype clone were sequenced. ST, hierarchical clusters (HC), serotype, resistome, and virulome were determined using EnteroBase, the CGE website, and local BLAST. The ST301 general phylogeny shows two groups. Group A (n = 25) is mainly composed of enteropathogenic E. coli, whereas group B (n = 55) includes mostly EHEC. Three serotypes, O186:H2, O45:H2 and O55:H9, share the same virulome as one of the O80:H2 sub-clones from which they derive subsequent O-antigen switches. The O55:H9 clone, mainly present in France (n = 29), as well as in the UK (n = 5) and Germany (n = 1), has a low background of genetic diversity (four HC20), although it has three Stx subtypes, an H-antigen switch, and genes encoding the major extra-intestinal VF yersiniabactin, and extended-spectrum beta-lactamases. Diverse heteropathotype clones genetically close to the O80:H2 clone are present among the ST301, requiring close European monitoring, especially the virulent O55:H9 clone.
Open AccessEmergence of New ST301 Shiga Toxin-Producing Escherichia coli Clones Harboring Extra-Intestinal Virulence Traits in Europe
O80:H2 enterohemorrhagic Escherichia coli (EHEC) of sequence type ST301 is one of the main serotypes causing European hemolytic and uremic syndrome, but also invasive infections, due to extra-intestinal virulence factors (VFs). Here, we determined whether other such heteropathotypes exist among ST301. EnteroBase was screened for ST301 strains that were included in a general SNP-phylogeny. French strains belonging to a new heteropathotype clone were sequenced. ST, hierarchical clusters (HC), serotype, resistome, and virulome were determined using EnteroBase, the CGE website, and local BLAST. The ST301 general phylogeny shows two groups. Group A (n = 25) is mainly composed of enteropathogenic E. coli, whereas group B (n = 55) includes mostly EHEC. Three serotypes, O186:H2, O45:H2 and O55:H9, share the same virulome as one of the O80:H2 sub-clones from which they derive subsequent O-antigen switches. The O55:H9 clone, mainly present in France (n = 29), as well as in the UK (n = 5) and Germany (n = 1), has a low background of genetic diversity (four HC20), although it has three Stx subtypes, an H-antigen switch, and genes encoding the major extra-intestinal VF yersiniabactin, and extended-spectrum beta-lactamases. Diverse heteropathotype clones genetically close to the O80:H2 clone are present among the ST301, requiring close European monitoring, especially the virulent O55:H9 clone.
- Open Access
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (STEC-HUS) is a form of thrombotic microangiopathy secondary to an infection by an enterohemorrhagic E. coli. Historically considered a pediatric disease, its presentation has been described as typical, with bloody diarrhea at the forefront. However, in adults, the clinical presentation is more diverse and makes the early diagnosis hazardous. In this review, we review the epidemiology, most important outbreaks, physiopathology, clinical presentation and prognosis of STEC-HUS, focusing on the differential features between pediatric and adult disease. We show that the clinical presentation of STEC-HUS in adults is far from typical and marked by the prevalence of neurological symptoms and a poorer prognosis. Of note, we highlight knowledge gaps and the need for studies dedicated to adult patients. The differences between pediatric and adult patients have implications for the treatment of this disease, which remains a public health threat and lack a specific treatment.
Open AccessShiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management
Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome (STEC-HUS) is a form of thrombotic microangiopathy secondary to an infection by an enterohemorrhagic E. coli. Historically considered a pediatric disease, its presentation has been described as typical, with bloody diarrhea at the forefront. However, in adults, the clinical presentation is more diverse and makes the early diagnosis hazardous. In this review, we review the epidemiology, most important outbreaks, physiopathology, clinical presentation and prognosis of STEC-HUS, focusing on the differential features between pediatric and adult disease. We show that the clinical presentation of STEC-HUS in adults is far from typical and marked by the prevalence of neurological symptoms and a poorer prognosis. Of note, we highlight knowledge gaps and the need for studies dedicated to adult patients. The differences between pediatric and adult patients have implications for the treatment of this disease, which remains a public health threat and lack a specific treatment.
- 1 December 2020
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 98 (4) , 115177
Be aware of Shiga-toxin 2f-producing Escherichia coli: case report and false-negative results with certain rapid molecular panels
- 1 December 2020
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 98 (4) , 115177
Be aware of Shiga-toxin 2f-producing Escherichia coli: case report and false-negative results with certain rapid molecular panels
- Top Cited PapersOpen Access
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
The severity of human infection by one of the many Shiga toxin-producing Escherichia coli (STEC) is determined by a number of factors: the bacterial genome, the capacity of human societies to prevent foodborne epidemics, the medical condition of infected patients (in particular their hydration status, often compromised by severe diarrhea), and by our capacity to devise new therapeutic approaches, most specifically to combat the bacterial virulence factors, as opposed to our current strategies that essentially aim to palliate organ deficiencies. The last major outbreak in 2011 in Germany, which killed more than 50 people in Europe, was evidence that an effective treatment was still lacking. Herein, we review the current knowledge of STEC virulence, how societies organize the prevention of human disease, and how physicians treat (and, hopefully, will treat) its potentially fatal complications. In particular, we focus on STEC-induced hemolytic and uremic syndrome (HUS), where the intrusion of toxins inside endothelial cells results in massive cell death, activation of the coagulation within capillaries, and eventually organ failure.
Top Cited PapersOpen AccessShiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
The severity of human infection by one of the many Shiga toxin-producing Escherichia coli (STEC) is determined by a number of factors: the bacterial genome, the capacity of human societies to prevent foodborne epidemics, the medical condition of infected patients (in particular their hydration status, often compromised by severe diarrhea), and by our capacity to devise new therapeutic approaches, most specifically to combat the bacterial virulence factors, as opposed to our current strategies that essentially aim to palliate organ deficiencies. The last major outbreak in 2011 in Germany, which killed more than 50 people in Europe, was evidence that an effective treatment was still lacking. Herein, we review the current knowledge of STEC virulence, how societies organize the prevention of human disease, and how physicians treat (and, hopefully, will treat) its potentially fatal complications. In particular, we focus on STEC-induced hemolytic and uremic syndrome (HUS), where the intrusion of toxins inside endothelial cells results in massive cell death, activation of the coagulation within capillaries, and eventually organ failure.